Radium-223 dichloride treatment for prostate cancer with bone metastases: A symptomatic outcome review of 12 months experience

被引:0
|
作者
Lee, H. H. [1 ]
McAddy, N. C. [1 ]
O'Sullivan, P. [1 ]
Crawley, P. [1 ]
Beesley, S. [2 ]
Naji, M. [1 ]
机构
[1] Maidstone & Tunbridge Wells NHS Trust, Nucl Med Dept, Maidstone, Kent, England
[2] Maidstone & TunbridgeWells NHS Trust, Dept Oncol, Maidstone, Kent, England
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EPW18
引用
收藏
页码:S214 / S215
页数:2
相关论文
共 50 条
  • [41] Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
    Parker, Christopher C.
    Coleman, Robert E.
    Sartor, Oliver
    Vogelzang, Nicholas J.
    Bottomley, David
    Heinrich, Daniel
    Helle, Svein I.
    O'Sullivan, Joe M.
    Fossa, Sophie D.
    Chodacki, Ales
    Wiechno, Pawel
    Logue, John
    Seke, Mihalj
    Widmark, Anders
    Johannessen, Dag Clement
    Hoskin, Peter
    James, Nicholas D.
    Solberg, Arne
    Syndikus, Isabel
    Kliment, Jan
    Wedel, Steffen
    Boehmer, Sibylle
    Dall'Oglio, Marcos
    Franzen, Lars
    Bruland, Oyvind S.
    Petrenciuc, Oana
    Staudacher, Karin
    Li, Rui
    Nilsson, Sten
    EUROPEAN UROLOGY, 2018, 73 (03) : 427 - 435
  • [42] Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
    Takalkar, Amol
    Paryani, Bhavna
    Skweres, Justin
    Adams, Scott
    Devarakonda, Srinivas
    Dhawan, Manish
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [43] Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
    Wissing, Michel D.
    van Leeuwen, Fijs W. B.
    van der Pluijm, Gabri
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2013, 19 (21) : 5822 - 5827
  • [44] Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases
    Kazuma Ogawa
    Takuma Higashi
    Kenji Mishiro
    Hiroshi Wakabayashi
    Kazuhiro Shiba
    Akira Odani
    Seigo Kinuya
    Scientific Reports, 10
  • [45] Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases
    Ogawa, Kazuma
    Higashi, Takuma
    Mishiro, Kenji
    Wakabayashi, Hiroshi
    Shiba, Kazuhiro
    Odani, Akira
    Kinuya, Seigo
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
    Kapoor, Anil
    Wong, Nathan C.
    Wang, Yuding
    Mukherjee, Som
    Hotte, Sebastien
    Dayes, Ian
    Lukka, Himu
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (04) : 437 - 438
  • [47] Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
    Nobuaki Matsubara
    Satsohi Nagamori
    Yoshiaki Wakumoto
    Hirotsugu Uemura
    Go Kimura
    Akira Yokomizo
    Hiroaki Kikukawa
    Atsushi Mizokami
    Takeo Kosaka
    Naoya Masumori
    Yoshihide Kawasaki
    Junji Yonese
    Yasutomo Nasu
    Satoshi Fukasawa
    Takayuki Sugiyama
    Seigo Kinuya
    Makoto Hosono
    Iku Yamaguchi
    Hirokazu Tsutsui
    Hiroji Uemura
    International Journal of Clinical Oncology, 2018, 23 : 173 - 180
  • [48] Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
    Matsubara, Nobuaki
    Nagamori, Satsohi
    Wakumoto, Yoshiaki
    Uemura, Hirotsugu
    Kimura, Go
    Yokomizo, Akira
    Kikukawa, Hiroaki
    Mizokami, Atsushi
    Kosaka, Takeo
    Masumori, Naoya
    Kawasaki, Yoshihide
    Yonese, Junji
    Nasu, Yasutomo
    Fukasawa, Satoshi
    Sugiyama, Takayuki
    Kinuya, Seigo
    Hosono, Makoto
    Yamaguchi, Iku
    Tsutsui, Hirokazu
    Uemura, Hiroji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 173 - 180
  • [49] Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review
    Cursano, M. C.
    Iuliani, M.
    Casadei, C.
    Stellato, M.
    Tonini, G.
    Paganelli, G.
    Santini, D.
    De Giorgi, U.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 146
  • [50] Efficacy of radium-223 dichloride in castration-resistant metastatic prostate cancer
    Sobrevilla Calvo, Pedro de Jesus
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 26 - 27